NCT05890755

Brief Summary

Healthy subjects will be invited to fill out a questionnaire regarding falls and balance skills followed by normal walking trials on a treadmill at 9 different speeds (0.28-1.4 m/s). Key gait parameters for the normative database will be collected. During the perturbation trials, the subjects will walk at a constant speed (1.2 m/s). The treadmill belts are ac, - or decelerated during the perturbations according to three different perturbation algorithms with varying perturbation onset. Movements will be analyzed by 3D motion capture, force plates, surface electromyography and IMU sensors. All methods are non-invasive and commonly used in the field of biomechanics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 31, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 6, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

June 6, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 6, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 6, 2024

Completed
Last Updated

August 28, 2025

Status Verified

August 1, 2025

Enrollment Period

1.5 years

First QC Date

March 31, 2023

Last Update Submit

August 20, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Calculation of Margins of Stability (MoS) in anterior-posterior direction at foot contact

    Difference between base of support and interpolated center of mass (mm), based on 3D motion capture.

    Once during visit 1

  • Step length at baseline, before (Pre) and after (Recovery step 1-10) perturbation

    Once during visit 1

Secondary Outcomes (12)

  • Step width at foot contact of baseline, before (Pre) and Recovery steps 1-10

    Once during visit 1

  • Calculation of Margin of stability medial-lateral direction at foot contact of baseline, before (Pre) and Recovery steps 1-10

    Once during visit 1

  • Maximal trunk velocity during gait cycle at of baseline, before (Pre) and Recovery steps 1-10 to detect fast trunk movement to gain balance

    Once during visit 1

  • 3D kinematic gait profiles to analyze detailed movement patterns/strategies

    Once during visit 1

  • EMG analysis to detect reaction time and activity patterns of different leg muscles

    Once during visit 1

  • +7 more secondary outcomes

Study Arms (2)

Healthy participants between 18 and 40 years of age

Other: Mechanical pertubation

Healthy participants between 60 and 80 years of age

Other: Mechanical pertubation

Interventions

Acceleration or deacceleration of one treadmill gait belt.

Healthy participants between 18 and 40 years of ageHealthy participants between 60 and 80 years of age

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy population

You may qualify if:

  • Healthy subjects aged 18-40 years and 60-80 years
  • Ability to walk at minimum 30 minutes at a regular pace without assistance or breaks
  • Written informed consent as documented by signature (see informed consent form)

You may not qualify if:

  • Women who are pregnant or breast feeding
  • Current neurological problems affecting walking function and balance
  • Current orthopedic problems affecting upper and lower extremity movements
  • History of alcohol abuse or the intake of psychotropic drugs
  • History of major cardiac condition (e.g., infarction, insufficiency (NYHA II-IV))
  • History of major pulmonary condition (e.g., chronic obstructive pulmonary disease (GOLD II-IV))
  • Current major depression or psychosis
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia
  • Fever of unknown origin

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Balgrist Campus

Zurich, Canton of Zurich, 8008, Switzerland

Location

MeSH Terms

Conditions

Gait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Linard Filli, Dr.

    University of Zurich

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 31, 2023

First Posted

June 6, 2023

Study Start

June 6, 2023

Primary Completion

December 6, 2024

Study Completion

December 6, 2024

Last Updated

August 28, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations